Healius (ASX:HLS) entered a binding agreement to sell its Lumus Imaging subsidiary to funds managed by Affinity Equity Partners in a deal that values the business at AU$965 million, according to a Monday filing with the Australian bourse.
The sale is expected to reap AU$835 million in proceeds after repayment of equipment leases and more than AU$800 million after transaction fees, separation costs, and other fees, the filing stated.
The deal is expected to close in Q1 2025, subject to Foreign Investment Review Board approval, according to the filing.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。